Skip to main content
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1986 Aug;67(4):481–491.

A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis.

P G Tipping, N M Thomson, S R Holdsworth
PMCID: PMC2013054  PMID: 3741774

Abstract

The effect of fibrinolysis with Streptokinase and defibrination with Ancrod on the progression of established fibrin-related glomerular injury was assessed in rabbits developing anti-glomerular basement membrane antibody-induced glomerulonephritis. Untreated rabbits developed renal failure and a severe crescentic nephritis with prominent fibrin deposition after 5 days. Rabbits with established injury and glomerular fibrin deposition were treated with Streptokinase or Ancrod over the last 4 days of this model. Both treatments resulted in significant protection from loss of renal function and reduced crescent formation by day 5. Glomerular fibrin deposition was also significantly reduced by both agents, although Streptokinase produced a greater reduction than Ancrod. Two further groups of rabbits with advanced disease, were treated over the last two days of this model. Although treatment reduced glomerular fibrin deposition, no protection from loss of renal function was observed. These studies indicate that both treatments were effective, if used early, in preserving renal function in established fibrin related glomerulonephritis, but they did not effect the outcome of more advanced disease. Both agents prevented further glomerular fibrin deposition, although only early treatment with Streptokinase reduced glomerular fibrin to below pre-treatment levels.

Full text

PDF
483

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burrow C. R., Walker W. G., Bell W. R., Gatewood O. B. Streptokinase salvage of renal function after renal vein thrombosis. Ann Intern Med. 1984 Feb;100(2):237–238. doi: 10.7326/0003-4819-100-2-237. [DOI] [PubMed] [Google Scholar]
  2. Crowley J. P., Matarese R. A., Quevedo S. F., Garella S. Fibrinolytic therapy for bilateral renal vein thrombosis. Arch Intern Med. 1984 Jan;144(1):159–160. [PubMed] [Google Scholar]
  3. Harrington J. T. Thrombolytic therapy in renal vein thrombosis. Arch Intern Med. 1984 Jan;144(1):33–34. [PubMed] [Google Scholar]
  4. Holdsworth S. R., Thomson N. M., Glasgow E. F., Dowling J. P., Atkins R. C. Tissue culture of isolated glomeruli in experimental crescentic glomerulonephritis. J Exp Med. 1978 Jan 1;147(1):98–109. doi: 10.1084/jem.147.1.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Naish P. F., Evans D. J., Peters D. K. The effects of defibrination with ancrod in experimental allergic glomerular injury. Clin Exp Immunol. 1975 May;20(2):303–309. [PMC free article] [PubMed] [Google Scholar]
  6. Pollak V. E., Glueck H. I., Weiss M. A., Lebron-Berges A., Miller M. A. Defibrination with ancrod in glomerulonephritis: effects on clinical and histologic findings and on blood coagulation. Am J Nephrol. 1982;2(4):195–207. doi: 10.1159/000166646. [DOI] [PubMed] [Google Scholar]
  7. Thomson N. M., Simpson I. J., Peters D. K. A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis. Clin Exp Immunol. 1975 Feb;19(2):301–308. [PMC free article] [PubMed] [Google Scholar]
  8. VASSALLI P., MCCLUSKEY R. T. THE PATHOGENIC ROLE OF THE COAGULATION PROCESS IN RABBIT MASUGI NEPHRITIS. Am J Pathol. 1964 Oct;45:653–677. [PMC free article] [PubMed] [Google Scholar]

Articles from British journal of experimental pathology are provided here courtesy of Wiley

RESOURCES